Eucure Biopharma’s Bispecific Antibody Licensing Agreement with Chipscreen NewWay

JunHe advised Eucure Biopharma on the deal.Biocytogen Pharmaceuticals (Beijing) Co., Ltd. and Shenzhen Chipscreen Biosciences Ltd. and Chengdu Chipscreen NewWay Biosciences Co., Ltd. had reached an exclusive license…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Maha Kanaan

Author: Maha Kanaan

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here